Overexpression of claudin-4 in cholangiocarcinoma tissues and its possible role in tumor metastasis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue SUPPL.1, 2012, Pages 71-76

  Bunthot, Suphawadee ^a   Obchoei, Sumalee ^a   Kraiklang, Rattaphol ^a   Pirojkul, Chawalit ^a   Wongkham, Sopit ^a   Wongkham, Chaisiri ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Bile duct cancer; CLDN4; Invasion; Migration; Proliferation

Indexed keywords

CLAUDIN 4;

ANIMAL; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CELL PROLIFERATION; DRUG EFFECTS; HUMAN; INTRAHEPATIC BILE DUCT; TUMOR CELL LINE;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; CLAUDIN-4; HUMANS;

EID: 84874030860     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.KKSuppl.71     Document Type: Article

References (32)

1. Agarwal R, D'Souza T, Morin PJ (2005). Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res, 65, 7378-85.
2. Balda MS, Garrett MD, Matter K (2003). The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol, 160, 423-32.
3. Bragazzi M, Cardinale V, Carpino G, et al (2012). Cholangiocarcinoma: epidemiology and risk factors. Transl Gastrointest Cancer, 1, 21-32.
4. Chakrabarti G, McClane BA (2005). The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol, 7, 129-46.
5. Hamazaki Y, Itoh M, Sasaki H, et al (2002). Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem, 277, 455-61.
6. Hwang T, Lee L, Wang C, et al (2010). Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer. Experimental and Therapeutic Medicine, 1, 789-97.
7. Itoh M, Furuse M, Morita K, et al (1999). Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol, 147, 1351-63.
8. Junking M, Wongkham C, Sripa B, et al (2008). Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer, 44, 619-26.
9. Katahira J, Sugiyama H, Inoue N, et al (1997). Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem, 272, 26652-8.
10. Kominsky SL, Tyler B, Sosnowski J, et al (2007). Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Cancer Res, 67, 7977-82.
11. Landis SH, Murray T, Bolden S, et al (1998). Cancer statistics. CA Cancer J Clin, 48, 6-29.
12. Li J, Chigurupati S, Agarwal R, et al (2009). Possible angiogenic roles for claudin-4 in ovarian cancer. Cancer Biol Ther, 8, 1806-14.
13. Lodi C, Szabo E, Holczbauer A, et al (2006). Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol, 19, 460-9.
14. Madara JL, Parkos C, Colgan S, et al (1992). The movement of solutes and cells across tight junctions. Ann N Y Acad Sci, 664, 47-60.
15. Maruyama M, Kobayashi N, Westerman KA, et al (2004). Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation, 77, 446-51.
16. Matter K, Aijaz S, Tsapara A, et al (2005). Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol, 17, 453-8.
17. Michl P, Barth C, Buchholz M, et al (2003). Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res, 63, 6265-71.
18. Michl P, Buchholz M, Rolke M, et al (2001). Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology, 121, 678-84.
19. Mooradian DL, McCarthy JB, Cameron JD, et al (1992). Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin. Invest Ophthalmol Vis Sci, 33, 3034-40.
20. Nakamura T, Blechman J, Tada S, et al (2000). huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proc Natl Acad Sci USA, 97, 7284-9.
21. Nemeth Z, Szasz AM, Tatrai P, et al (2009). Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers. J Histochem Cytochem, 57, 113-21.
22. Nishino R, Honda M, Yamashita T, et al (2008). Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J Hepatol, 49, 207-16.
23. Patel T (2002). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2, 10.
24. Peralta Soler A, Mullin JM, Knudsen KA, et al (1996). Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol, 270, 869-79.
25. Rangel LB, Agarwal R, D'Souza T, et al (2003). Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res, 9, 2567-75.
26. Riehl TE, Stenson WF (1994). Mechanisms of transit of lipid mediators of inflammation and bacterial peptides across intestinal epithelia. Am J Physiol, 267, 687-95.
27. Roh MH, Liu CJ, Laurinec S, et al (2002). The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions. J Biol Chem, 277, 27501-9.
28. Soini Y (2005). Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology, 46, 551-60.
29. Sripa B, Leungwattanawanit S, Nitta T, et al (2005). Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol, 11, 3392-7.
30. Takehara M, Nishimura T, Mima S, et al (2009). Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull, 32, 825-31.
31. Wu X, Hepner K, Castelino-Prabhu S, et al (2000). Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA, 97, 4233-8.
32. Yamamoto Y, Nishimura N, Morimoto S, et al (2003). Distinct roles of Rab3B and Rab13 in the polarized transport of apical, basolateral, and tight junctional membrane proteins to the plasma membrane. Biochem Biophys Res Commun, 308, 270-5.